aliskiren and Ventricular-Dysfunction

aliskiren has been researched along with Ventricular-Dysfunction* in 1 studies

Other Studies

1 other study(ies) available for aliskiren and Ventricular-Dysfunction

Article	Year
Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction. American journal of physiology. Heart and circulatory physiology, 2019, 03-01, Volume: 316, Issue:3 Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antineoplastic Agents; Bevacizumab; Cardiotoxicity; Fumarates; Hydralazine; Male; Mice; Mice, Inbred C57BL; Perindopril; Renin-Angiotensin System; Sunitinib; Valsartan; Ventricular Dysfunction	2019

Article

Year

Role of renin-angiotensin system antagonists in the prevention of bevacizumab- and sunitinib-mediated cardiac dysfunction.

American journal of physiology. Heart and circulatory physiology, 2019, 03-01, Volume: 316, Issue:3

Topics: Amides; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Antineoplastic Agents; Bevacizumab; Cardiotoxicity; Fumarates; Hydralazine; Male; Mice; Mice, Inbred C57BL; Perindopril; Renin-Angiotensin System; Sunitinib; Valsartan; Ventricular Dysfunction

2019